• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸菌体外和体内免疫调节特性之间的相关性

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.

作者信息

Foligne Benoit, Nutten Sophie, Grangette Corinne, Dennin Véronique, Goudercourt Denise, Poiret Sabine, Dewulf Joelle, Brassart Dominique, Mercenier Annick, Pot Bruno

机构信息

Bactéries Lactiques and Immunité des Muqueuses, Institut Pasteur de Lille, 1 Rue du Professeur Calmette, Lille cedex F-59019, France.

出版信息

World J Gastroenterol. 2007 Jan 14;13(2):236-43. doi: 10.3748/wjg.v13.i2.236.

DOI:10.3748/wjg.v13.i2.236
PMID:17226902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4065951/
Abstract

AIM

To investigate the correlation between in vitro and in vivo immunomodulation potential of the probiotic strain and its ability to prevent experimental colitis in mice.

METHODS

In vitro immunomodulation was assessed by measuring interleukin (IL)-12p70, IL-10, tumor necrosis factor alpha (TNFalpha) and interferon gamma (IFNgamma) release by human peripheral blood mononuclear cells (PBMCs) after 24 h stimulation with 13 live bacterial strains. A murine model of acute TNBS-colitis was next used to evaluate the prophylactic protective capacity of the same set of strains.

RESULTS

A strain-specific in vivo protection was observed. The strains displaying an in vitro potential to induce higher levels of the anti-inflammatory cytokine IL-10 and lower levels of the inflammatory cytokine IL-12, offered the best protection in the in vivo colitis model. In contrast, strains leading to a low IL-10/IL-12 cytokine ratio could not significantly attenuate colitis symptoms.

CONCLUSION

These results show that we could predict the in vivo protective capacity of the studied lactic acid bacteria (LAB) based on the cytokine profile we established in vitro. The PBMC-based assay we used may thus serve as a useful primary indicator to narrow down the number of candidate strains to be tested in murine models for their anti-inflammatory potential.

摘要

目的

研究益生菌菌株的体外和体内免疫调节潜力与其预防小鼠实验性结肠炎能力之间的相关性。

方法

通过测量13种活细菌菌株刺激人外周血单核细胞(PBMCs)24小时后白细胞介素(IL)-12p70、IL-10、肿瘤坏死因子α(TNFα)和干扰素γ(IFNγ)的释放来评估体外免疫调节。接下来使用急性TNBS结肠炎小鼠模型评估同一组菌株的预防性保护能力。

结果

观察到菌株特异性的体内保护作用。在体外具有诱导更高水平抗炎细胞因子IL-10和更低水平炎性细胞因子IL-12潜力的菌株,在体内结肠炎模型中提供了最佳保护。相比之下,导致IL-10/IL-12细胞因子比率较低的菌株不能显著减轻结肠炎症状。

结论

这些结果表明,我们可以根据在体外建立的细胞因子谱预测所研究的乳酸菌(LAB)的体内保护能力。因此,我们使用的基于PBMC的检测方法可能作为一种有用的初步指标,以缩小在小鼠模型中测试其抗炎潜力的候选菌株数量。

相似文献

1
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.乳酸菌体外和体内免疫调节特性之间的相关性
World J Gastroenterol. 2007 Jan 14;13(2):236-43. doi: 10.3748/wjg.v13.i2.236.
2
Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.益生菌酵母:各种非致病性菌株在实验性结肠炎小鼠中的抗炎潜力。
World J Gastroenterol. 2010 May 7;16(17):2134-45. doi: 10.3748/wjg.v16.i17.2134.
3
Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.益生菌膳食补充剂Lactibiane Tolérance的抗炎潜力:体外和体内研究
Clin Nutr. 2006 Dec;25(6):994-1003. doi: 10.1016/j.clnu.2006.03.006. Epub 2006 May 15.
4
Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss.从蒙古发酵马奶酒中分离出的瑞士乳杆菌NS8的益生菌和抗炎特性
BMC Microbiol. 2015 Oct 2;15:196. doi: 10.1186/s12866-015-0525-2.
5
Probiotic properties of non-conventional lactic acid bacteria: immunomodulation by Oenococcus oeni.非常规乳酸菌的益生菌特性:Oenococcus oeni 的免疫调节作用。
Int J Food Microbiol. 2010 Jun 15;140(2-3):136-45. doi: 10.1016/j.ijfoodmicro.2010.04.007. Epub 2010 Apr 10.
6
Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.发酵乳杆菌ACA-DC 179在体外显示出益生菌潜力,并在小鼠模型中预防三硝基苯磺酸(TNBS)诱导的结肠炎和沙门氏菌感染。
Int J Food Microbiol. 2008 Jan 15;121(1):18-26. doi: 10.1016/j.ijfoodmicro.2007.10.013. Epub 2007 Nov 6.
7
Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.在三硝基苯磺酸(TNBS)诱导的慢性结肠炎模型中,递送白细胞介素-10(IL-10)蛋白或互补DNA(cDNA)的乳酸乳球菌菌株的保护作用。
J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S12-7. doi: 10.1097/MCG.0000000000000235.
8
New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.通过结合体外和体内方法鉴定出用于炎症性肠病管理的新型益生菌菌株。
Benef Microbes. 2018 Feb 27;9(2):317-331. doi: 10.3920/BM2017.0097.
9
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.关于改进小鼠TNBS诱导的结肠炎模型在评估乳酸菌抗炎特性中应用的建议:技术和微生物学方面
Dig Dis Sci. 2006 Feb;51(2):390-400. doi: 10.1007/s10620-006-3143-x.
10
Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.不同乳酸杆菌和双歧杆菌菌株预防三硝基苯磺酸诱导的结肠炎与肠道上皮内淋巴细胞的γδT细胞和调节性T细胞扩增有关。
Inflamm Bowel Dis. 2009 Oct;15(10):1526-36. doi: 10.1002/ibd.20961.

引用本文的文献

1
Neuroimmune interactions: The bridge between inflammatory bowel disease and the gut microbiota.神经免疫相互作用:炎症性肠病与肠道微生物群之间的桥梁。
Clin Transl Med. 2025 May;15(5):e70329. doi: 10.1002/ctm2.70329.
2
Combining in vivo and in vitro approaches to better understand host-pathogen nutritional interactions.结合体内和体外方法以更好地理解宿主-病原体营养相互作用。
J Anim Ecol. 2025 Apr;94(4):657-669. doi: 10.1111/1365-2656.70000. Epub 2025 Feb 7.
3
"Gut" to grips with the science of the microbiome - a symposium report.《“肠道”深入探究微生物组学——研讨会报告》
Gut Microbiome (Camb). 2024 Nov 29;5:e11. doi: 10.1017/gmb.2024.8. eCollection 2024.
4
A Synbiotic Combining Chitin-Glucan and NCFM Induces a Colonic Molecular Signature Soothing Intestinal Pain and Inflammation in an Animal Model of IBS.一种包含几丁质-葡聚糖和 NCFM 的合生菌可诱导 IBS 动物模型的结肠分子特征,从而舒缓肠道疼痛和炎症。
Int J Mol Sci. 2024 Oct 5;25(19):10732. doi: 10.3390/ijms251910732.
5
Extracellular vesicles from a novel strain suppress inflammation and promote M2 macrophage polarization.新型 株来源的细胞外囊泡抑制炎症反应并促进 M2 型巨噬细胞极化。
Front Immunol. 2024 Aug 23;15:1459213. doi: 10.3389/fimmu.2024.1459213. eCollection 2024.
6
Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure?肝移植患者并发憩室病。它会影响术后住院时间吗?
Clin Exp Hepatol. 2023 Dec;9(4):344-350. doi: 10.5114/ceh.2023.132255. Epub 2023 Nov 13.
7
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.一种新兴策略:益生菌通过调节肠道微生物组来增强肿瘤免疫疗法的效果。
Gut Microbes. 2024 Jan-Dec;16(1):2341717. doi: 10.1080/19490976.2024.2341717. Epub 2024 May 8.
8
Recombinant probiotic delivering P62 mitigates moderate colitis in mice.递送P62的重组益生菌可减轻小鼠的中度结肠炎。
Front Microbiol. 2024 Apr 4;15:1309160. doi: 10.3389/fmicb.2024.1309160. eCollection 2024.
9
The effect of probiotic Bl-04 on innate antiviral responses .益生菌Bl-04对先天性抗病毒反应的影响
Heliyon. 2024 Apr 15;10(8):e29588. doi: 10.1016/j.heliyon.2024.e29588. eCollection 2024 Apr 30.
10
Effect of the dietary supplement PERMEAPROTECT+ TOLERANCE© on gut permeability in a human co-culture epithelial and immune cells model.膳食补充剂PERMEAPROTECT+ TOLERANCE©对人上皮细胞与免疫细胞共培养模型中肠道通透性的影响。
Heliyon. 2024 Mar 27;10(7):e28320. doi: 10.1016/j.heliyon.2024.e28320. eCollection 2024 Apr 15.

本文引用的文献

1
Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.双歧杆菌通过抑制脂多糖诱导的核因子κB激活发挥抗炎作用。
World J Gastroenterol. 2006 Jun 21;12(23):3729-35. doi: 10.3748/wjg.v12.i23.3729.
2
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.关于改进小鼠TNBS诱导的结肠炎模型在评估乳酸菌抗炎特性中应用的建议:技术和微生物学方面
Dig Dis Sci. 2006 Feb;51(2):390-400. doi: 10.1007/s10620-006-3143-x.
3
Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans.人类不同淋巴组织中树突状细胞对共生菌和病原菌的细胞因子差异反应。
Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G839-45. doi: 10.1152/ajpgi.00112.2005. Epub 2005 Nov 17.
4
Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.唾液乳杆菌唾液亚种益生菌在大鼠结肠炎TNBS模型中的预防作用。
World J Gastroenterol. 2005 Sep 7;11(33):5185-92. doi: 10.3748/wjg.v11.i33.5185.
5
Probiotics as a treatment strategy for gastrointestinal diseases?益生菌作为胃肠道疾病的一种治疗策略?
Digestion. 2005;72(1):57-68. doi: 10.1159/000087638. Epub 2005 Aug 18.
6
Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids.合成修饰磷壁酸的植物乳杆菌突变体的抗炎能力增强。
Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10321-6. doi: 10.1073/pnas.0504084102. Epub 2005 Jun 28.
7
Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.干酪乳杆菌的黏膜定植可减轻因暴露于三硝基苯磺酸而引起的屏障损伤。
Gut. 2005 Jul;54(7):955-9. doi: 10.1136/gut.2004.056101.
8
Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.益生菌乳酸杆菌诱导的小鼠慢性炎症性肠病改善与固有层单核细胞中促炎细胞因子的下调有关。
Clin Exp Immunol. 2005 Jun;140(3):417-26. doi: 10.1111/j.1365-2249.2005.02790.x.
9
Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.炎症性肠病中的益生菌:黏膜给药途径和全身给药途径可能产生相似的效果。
Gut. 2005 May;54(5):727-8.
10
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.肠易激综合征中的乳酸菌和双歧杆菌:症状反应及与细胞因子谱的关系
Gastroenterology. 2005 Mar;128(3):541-51. doi: 10.1053/j.gastro.2004.11.050.